Assessing Analytical Similarity of Proposed Amgen Biosimilar ABP 501 to Adalimumab

BACKGROUND: ABP 501 is being developed as a biosimilar to adalimumab. Comprehensive comparative analytical characterization studies have been conducted and completed. OBJECTIVE: The objective of this study was to assess analytical similarity between ABP 501 and two adalimumab reference products (RPs...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jennifer, Eris, Tamer, Li, Cynthia, Cao, Shawn, Kuhns, Scott
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972872/
https://www.ncbi.nlm.nih.gov/pubmed/27461107
http://dx.doi.org/10.1007/s40259-016-0184-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972872/
https://www.ncbi.nlm.nih.gov/pubmed/27461107
http://dx.doi.org/10.1007/s40259-016-0184-3

Ejemplares similares